News

Oxford BioMedica plc, the leading gene-based biopharmaceutical company, announces that the US Food and Drug Administration (FDA) has approved its Investigational New Drug (IND) application for the Phase I/IIa clinical development of UshStat®, a novel gene-based treatment for Usher...

Norgine, a leading European speciality pharmaceutical company and Jubilant Biosys Ltd., Bengaluru based subsidiary of Jubilant Life Sciences Ltd, an integrated pharma & life sciences company of India, announced today, that they have entered into a discovery partnership....

Agilent Technologies Inc. and Oxford Gene Technology today announced they have expanded an existing partnership into an exclusive agreement for Agilent to provide OGT with oligonucleotide microarrays and SureSelect target enrichment products for next-generation sequencing. ...

Teva Pharmaceutical Industries Ltd.announced that it has completed its acquisition of Cephalon, Inc. (NASDAQ: CEPH).  The combined company will have a significant presence in over 60 countries and generated approximately $20 billion in revenues on a pro-forma basis for...

Ranbaxy Inc., a research-based pharmaceutical company that manufactures generic product formulations, OTC and branded drug products, has been honored with the New Jersey Business Industry Association’s (NJBIA) Award for Excellence in Business Expansion and Economic Contribution to the...

As global pharmas race to grab a piece of the growing Chinese drug market, London-based drug giant AstraZeneca appears to be sticking to an R&D strategy that emphasizes partnerships with local stakeholders over buyouts to gain traction in...

Sanofi Pasteur, the vaccines division of Sanofi is donating to the World Health Organization a vaccine strain used for polio eradication. The biological material given by Sanofi Pasteur is the original viral seed used to produce large quantities...